115 assets in Hematopoietic And Lymphoid Cell Neoplasm

Therapeutic assets addressing Hematopoietic And Lymphoid Cell Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Palbociclib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Palmidrol Hematopoietic And Lymphoid Cell Neoplasm	Academic and Community Cancer Research United	P2	CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493 Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Pertuzumab Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Relatlimab Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Sapanisertib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Trastuzumab Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Trastuzumab Emtansine Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Ulixertinib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Vismodegib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Adavosertib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (52)
Daptomycin Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P2	CCC (52)
(+)-Vincristine Hematopoietic And Lymphoid Cell Neoplasm	Children's Oncology Group	P1/2	CCC (52)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Hematopoietic And Lymphoid Cell Neoplasm	Masonic Cancer Center, University of Minnesota	P2	CCC (51)
Dexasone Hematopoietic And Lymphoid Cell Neoplasm	Therapeutic Advances in Childhood Leukemia Consortium	P1/2	CCC (51)
Pirtobrutinib Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P2	CCC (51)
Taselisib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (51)
Copanlisib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (49)
Mesna Hematopoietic And Lymphoid Cell Neoplasm	St. Jude Children's Research Hospital	P1/2	CCC (48)
Relebactam Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P2	CCC (48)
Apamistamab-B10-Astatine At-211 Hematopoietic And Lymphoid Cell Neoplasm	Fred Hutchinson Cancer Center	P1/2	CC (47)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester) Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (47)
Itacitinib Hematopoietic And Lymphoid Cell Neoplasm	Douglas Johnson	P2	CC (47)
Recombinant Human Granulocyte Colony-Stimulating Factor Hematopoietic And Lymphoid Cell Neoplasm	Fred Hutchinson Cancer Center	P1/2	CC (47)
Dilanubicel Hematopoietic And Lymphoid Cell Neoplasm	Fred Hutchinson Cancer Center	P2	CC (46)
Teonanacatl Hematopoietic And Lymphoid Cell Neoplasm	Emory University	P1	CC (46)
Allogeneic Tcr-Enhanced Vδ2 T Cell Hematopoietic And Lymphoid Cell Neoplasm	Chinese PLA General Hospital	P1/2	CC (43)
Allo-Quadcar01-T Hematopoietic And Lymphoid Cell Neoplasm	AvenCell Therapeutics, Inc.	P1/2	CC (43)
Anti-Cd33 Car T-Cells Hematopoietic And Lymphoid Cell Neoplasm	iCell Gene Therapeutics	P1	CC (43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4 Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
Atezolizumab Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P1	CC (43)
Cabozantinib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P1	CC (43)
Fapi-46 Hematopoietic And Lymphoid Cell Neoplasm	Jonsson Comprehensive Cancer Center	P1	CC (43)
Human T Lymphoid Progenitor Hematopoietic And Lymphoid Cell Neoplasm	Assistance Publique - Hôpitaux de Paris	P1/2	CC (43)
Pembrolizumab Hematopoietic And Lymphoid Cell Neoplasm	City of Hope Medical Center	P1	CC (43)
Senti-202 Hematopoietic And Lymphoid Cell Neoplasm	Senti Biosciences	P1	CC (43)
Sotrovimab Hematopoietic And Lymphoid Cell Neoplasm	Fred Hutchinson Cancer Center	P1	CC (43)
Tcr Transduced T-Cells Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P1	CC (43)
Tgrx-814 Hematopoietic And Lymphoid Cell Neoplasm	Shenzhen TargetRx Co., Ltd.	P1/2	CC (43)
dt2216 Hematopoietic And Lymphoid Cell Neoplasm	Dialectic Therapeutics, Inc	P1	CC (42)
Ropidoxuridine Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P1	CC (41)
Alteplase Hematopoietic And Lymphoid Cell Neoplasm	M.D. Anderson Cancer Center	Early P1	C (39)
Bpx-501 T Cells Hematopoietic And Lymphoid Cell Neoplasm	Bellicum Pharmaceuticals	P1	C (39)
cd70-targeting car-t cells Hematopoietic And Lymphoid Cell Neoplasm	St. Jude Children's Research Hospital	P1	C (39)
Decitabine Hematopoietic And Lymphoid Cell Neoplasm	University of Alabama at Birmingham	P1	C (39)
Gilteritinib Hematopoietic And Lymphoid Cell Neoplasm	Kura Oncology, Inc.	P1	C (39)
Hydrocortisone Hematopoietic And Lymphoid Cell Neoplasm	Therapeutic Advances in Childhood Leukemia Consortium	P1	C (39)
Idarubicin Hematopoietic And Lymphoid Cell Neoplasm	Kura Oncology, Inc.	P1	C (39)
Ivaltinostat Hematopoietic And Lymphoid Cell Neoplasm	Machaon Biotherapeutics, Inc.	P1	C (39)
Nadravaleucel Hematopoietic And Lymphoid Cell Neoplasm	David Wald	P1	C (39)

Showing 51 to 100 of 115 assets

PreviousPage 2 of 3Next